Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab. Rev Alerg Mex [Internet]. 2025 Sep. 30 [cited 2026 Sep. 23];72(3):216. Available from: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/1490